BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19410618)

  • 1. Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.
    Morabito A; Dozin B; Salvi S; Pasciucco G; Balbi G; Laurent S; Pastorino S; Carli F; Truini M; Bruzzi P; Del Mastro L; Pistillo MP
    Hum Immunol; 2009 Jul; 70(7):492-5. PubMed ID: 19410618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Rolland P; Deen S; Scott I; Durrant L; Spendlove I
    Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
    Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA class I antigen and proteasome subunits LMP-2 and LMP-10 in primary vs. metastatic breast carcinoma lesions.
    Gobbi G; Mirandola P; Micheloni C; Solenghi E; Sponzilli I; Artico M; Soda G; Zanelli G; Pelusi G; Fiorini T; Cocco L; Vitale M
    Int J Oncol; 2004 Dec; 25(6):1625-9. PubMed ID: 15547699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition.
    Kitamura H; Torigoe T; Asanuma H; Honma I; Sato N; Tsukamoto T
    J Urol; 2007 Aug; 178(2):692-6. PubMed ID: 17574613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
    Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
    Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.
    Tang Q; Zhang J; Qi B; Shen C; Xie W
    Arch Med Res; 2009 May; 40(4):256-63. PubMed ID: 19608014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
    de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
    J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
    Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
    Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of human leukocyte antigen class I and II and beta 2-microglobulin expression in human herpesvirus-7-infected cells.
    Mirandola P; Sponzilli I; Solenghi E; Micheloni C; Rinaldi L; Gobbi G; Vitale M
    J Infect Dis; 2006 Apr; 193(7):917-26. PubMed ID: 16518752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
    Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
    Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA expression in choroidal melanomas: correlation with clinicopathological features.
    Krishnakumar S; Abhyankar D; Lakshmi SA; Pushparaj V; Shanmugam MP; Biswas J
    Curr Eye Res; 2004 Jun; 28(6):409-16. PubMed ID: 15512948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.